Affimed N.V.: Proprietary ROCK® platform enabling generation of multi-specific antibodies is basis for its collaboration with Genentech ($96M upfront / $5B potential) to develop NK-cell engager-based therapeutics. Pipeline includes NK cell engager AFM13 (CD30/CD16A) to enter Ph 2 registration study in CD30-positive PTCL and an investigator-sponsored study by MDACC of AFM13 combined with allogeneic NK cells in relapsed/refractory CD30-positive lymphoma. IND cleared for AFM24, the company’s innate cell engager that targets EGFR-expressing solid tumors.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe, USA
Clinical Stage
Phase l or ll
Disease Space
Hematology, Immuno-Oncology, Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
Website:
http://www.affimed.com
Profiles:
Address:
Im Neuenheimer Feld 582
Heidelberg, Baden-Wurttemberg 69120
Germany

Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13

  • Adi Hoess, Ph.D., Chief Executive Officer
  • Gregory Gin, Head of Investor Relations

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Lead Programs

AFM13

Disease Target CD30 Immune Cell Target CD16A

Indication Phase
Hodgkin lymphoma + PD-1 1
Hodgkin lymphoma 2
Hodgkin lymphoma + adoptive NK cells Pre-clinical
CD30-positive lymphoma 2

AFM24

Disease Target EGFRwt Immune Cell Target CD16A

Indication Phase
Solid tumors Pre-clinical

Top 10 Holders of Affimed N.V.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
NEA Management Co. 9.81 6,126,488 28.06 13F 2020-03-31
Millennium Management LLC 7.41 4,625,033 21.18 Stakes 2020-05-18
BlackRock Fund Advisors 5.07 3,164,961 14.50 13F 2020-03-31
Stonepine Capital Management LLC 4.81 3,000,000 13.74 13F 2020-03-31
Bain Capital Public Equity Management II LLC 3.66 2,283,428 10.46 13F 2020-03-31
Point72 Asset Management LP (Old) 2.72 1,700,000 7.79 13F 2020-03-31
683 Capital Management LLC 2.40 1,500,000 6.87 13F 2020-03-31
Fidelity Management & Research Co. LLC 2.04 1,276,276 5.85 13F 2020-03-31
State Street Corp. 1.91 1,190,695 5.45 13F 2020-03-31
DAFNA Capital Management LLC 1.82 1,133,401 5.19 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.